Browsing “January, 2023 - FSHD Society”

FDA Fast Track Designation for Avidity’s FSHD therapeutic

What does this mean for patients? An FDA Fast Track designation DOES NOT mean that the drug has been approved for use by patients. AOC 1020 is still a long […]

(Cautious) optimism in FSHD drug development

Patients are critical in helping to transform optimism into reality by Ken Kahtava, Chief Business Officer, FSHD Society Breakthroughs in FSHD research have identified the primary mechanism that causes FSHD. […]

Stay warm and safe